WHY UGANDA · - Why Uganda Uganda - An ideal production platform to serve the domestic and regional...

8
www.ugandainvest.go.ug 1 WHY UGANDA Pharmaceucals producon - Why Uganda Uganda - An ideal producon plaorm to serve the domesc and regional market Uganda combines a growing pharma market with access to the EAC market of 175 million people. With relavely high levels of educaon and skills and an investor-friendly environment, Uganda is a burgeoning pharmaceucal centre PHARMACEUTICALS

Transcript of WHY UGANDA · - Why Uganda Uganda - An ideal production platform to serve the domestic and regional...

Page 1: WHY UGANDA · - Why Uganda Uganda - An ideal production platform to serve the domestic and regional market Uganda combines a growing pharma market with access to the EAC market of

www.ugandainvest.go.ug 1

WHY UGANDA

Pharmaceuticals production- Why Uganda

Uganda - An idealproduction platformto serve the domesticand regional market

Uganda combines agrowing pharma marketwith access to the EACmarket of 175 millionpeople. With relativelyhigh levels of education and skills and an investor-friendlyenvironment, Ugandais a burgeoningpharmaceutical centre

PHAR

MAC

EUTI

CAL

S

Page 2: WHY UGANDA · - Why Uganda Uganda - An ideal production platform to serve the domestic and regional market Uganda combines a growing pharma market with access to the EAC market of

www.ugandainvest.go.ug 2

Uganda - Gateway to one of Africa’s largest pharmaceuticals marketDomestic Market Opportunity

Regional Market Opportunity

Page 3: WHY UGANDA · - Why Uganda Uganda - An ideal production platform to serve the domestic and regional market Uganda combines a growing pharma market with access to the EAC market of

www.ugandainvest.go.ug 2 www.ugandainvest.go.ug 3

Availability of a Skilled Workforce Workforce Recruitment, Training and Participation

Early-Mover Advantage

Management & Technical Employees

Management & Technical Employees

Labour force increase(average annual growth, 2018-2022)

Availability of employees (2017)

Page 4: WHY UGANDA · - Why Uganda Uganda - An ideal production platform to serve the domestic and regional market Uganda combines a growing pharma market with access to the EAC market of

www.ugandainvest.go.ug 4

Pharma Graduate Courses and Research Institutes

Pharma related colleges and courses in Uganda (2019)

Pharma related research institutions and research centres in Uganda (2019)

Political and Economic Stability and Security

No

No

College Course

Institution or Department

URL

URL

Page 5: WHY UGANDA · - Why Uganda Uganda - An ideal production platform to serve the domestic and regional market Uganda combines a growing pharma market with access to the EAC market of

www.ugandainvest.go.ug 4 www.ugandainvest.go.ug 5

Investor-Friendly

Regulatory Environment for the Pharmaceutical Sector

FDI Track Record

Labour Costs

Uganda - Cost Advantages for PharmaceuticalsInvestments

Page 6: WHY UGANDA · - Why Uganda Uganda - An ideal production platform to serve the domestic and regional market Uganda combines a growing pharma market with access to the EAC market of

www.ugandainvest.go.ug 6

Average annual labour costs for a highly skilledproduction operative, wages + social security (USD)

Tariffs and Local Sourcing Requirements

Electricity Costs

Special Zones and Incentives

Page 7: WHY UGANDA · - Why Uganda Uganda - An ideal production platform to serve the domestic and regional market Uganda combines a growing pharma market with access to the EAC market of

www.ugandainvest.go.ug 6 www.ugandainvest.go.ug 7

Pharmaceutical products proposed for 25% Common External Tariff (CET) inthe EAC

No Formulation

Pharmaceuticals Sector Size in Uganda

Medical Consumables Sector in Uganda

Chemicals (includes Pharmaceuticals) as % of manufacturing value added

Strength of the Pharmaceutical Industry in Uganda

Page 8: WHY UGANDA · - Why Uganda Uganda - An ideal production platform to serve the domestic and regional market Uganda combines a growing pharma market with access to the EAC market of

www.ugandainvest.go.ug 8

PHAR

MAC

EUTI

CAL

S

Get in touch

Sector information research carried out in collaboration with DFID, UK